• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rituximab for the treatment of systemic sclerosis-interstitial lung disease.

作者信息

Hughes Michael, Denton Christopher P, Khanna Dinesh

机构信息

Department of Rheumatology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK.

Department of Rheumatology, Royal Free Hospital, University College London, London, UK.

出版信息

Rheumatology (Oxford). 2021 Feb 1;60(2):489-491. doi: 10.1093/rheumatology/keaa675.

DOI:10.1093/rheumatology/keaa675
PMID:33244601
Abstract
摘要

相似文献

1
Rituximab for the treatment of systemic sclerosis-interstitial lung disease.利妥昔单抗治疗系统性硬化症相关间质性肺病
Rheumatology (Oxford). 2021 Feb 1;60(2):489-491. doi: 10.1093/rheumatology/keaa675.
2
Successful treatment with rituximab in a Japanese patient with systemic sclerosis-associated interstitial lung disease resistant to oral steroid and cyclophosphamide.利妥昔单抗成功治疗一名对口服类固醇和环磷酰胺耐药的日本系统性硬化症相关间质性肺病患者。
J Dermatol. 2018 Jun;45(6):e140-e141. doi: 10.1111/1346-8138.14189. Epub 2017 Dec 19.
3
Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease.利妥昔单抗治疗比环磷酰胺治疗更有效用于日本抗拓扑异构酶 I 阳性系统性硬皮病相关间质性肺病患者。
J Dermatol. 2019 Nov;46(11):1006-1013. doi: 10.1111/1346-8138.15079. Epub 2019 Sep 9.
4
Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease.利妥昔单抗治疗对泼尼松龙和免疫抑制剂耐药的系统性硬化症相关间质性肺病取得了前所未有的成功。
Scand J Rheumatol. 2017 May;46(3):247-252. doi: 10.1080/03009742.2016.1231341. Epub 2016 Nov 30.
5
Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: comment on the article by Yoo.利妥昔单抗治疗系统性硬化症相关间质性肺病：评 Yoo 等人的文章。
Rheumatol Int. 2011 Jun;31(6):841-2. doi: 10.1007/s00296-010-1485-3. Epub 2010 Apr 8.
6
Is biological therapy in systemic sclerosis the answer?生物疗法是系统性硬化症的答案吗？
Rheumatol Int. 2020 May;40(5):679-694. doi: 10.1007/s00296-020-04515-6. Epub 2020 Jan 20.
7
Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review.利妥昔单抗治疗系统性硬化症的疗效和安全性：法国回顾性研究和文献复习。
Autoimmun Rev. 2018 Jun;17(6):582-587. doi: 10.1016/j.autrev.2017.12.010. Epub 2018 Apr 7.
8
A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease.一项关于利妥昔单抗治疗系统性硬化症相关间质性肺病的多中心、开放标签、对比研究。
Semin Arthritis Rheum. 2017 Apr;46(5):625-631. doi: 10.1016/j.semarthrit.2016.10.003. Epub 2016 Oct 13.
9
Combination therapy with rituximab and mycophenolate mofetil in systemic sclerosis. A single-centre case series study.利妥昔单抗联合霉酚酸酯治疗系统性硬化症。单中心病例系列研究。
Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):142-145. Epub 2018 Sep 30.
10
Treatment Algorithms for Systemic Sclerosis According to Experts.根据专家的建议治疗系统性硬化症的方法。
Arthritis Rheumatol. 2018 Nov;70(11):1820-1828. doi: 10.1002/art.40560. Epub 2018 Sep 17.

引用本文的文献

1
Anti-topoisomerase 1 Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis.抗拓扑异构酶 1 抗体水平在系统性硬化症 B 细胞耗竭治疗后的变化。
Dokl Biochem Biophys. 2023 Aug;511(1):212-218. doi: 10.1134/S1607672923700266. Epub 2023 Oct 13.
2
State-of-the-art evidence in the treatment of systemic sclerosis.系统性硬化症治疗的最新证据。
Nat Rev Rheumatol. 2023 Apr;19(4):212-226. doi: 10.1038/s41584-023-00909-5. Epub 2023 Feb 27.
3
[Treatment of lung fibrosis in systemic rheumatic diseases (new treatment)].
[系统性风湿性疾病中的肺纤维化治疗（新疗法）]
Z Rheumatol. 2021 Oct;80(8):743-754. doi: 10.1007/s00393-021-01067-3. Epub 2021 Sep 10.
4
Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis.利妥昔单抗作为系统性硬化症患者自体造血干细胞移植后的一种治疗选择
J Pers Med. 2021 Jun 25;11(7):600. doi: 10.3390/jpm11070600.
5
A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response.一项采用强化B淋巴细胞清除方案治疗进行性系统性硬化症患者的3年观察性研究：临床和免疫反应
J Clin Med. 2021 Jan 14;10(2):292. doi: 10.3390/jcm10020292.